Virtus Fund Advisers’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-878
| Closed | -$23.5K | – | 123 |
|
|
2024
Q2 | $23.5K | Buy |
878
+164
| +23% | +$4.39K | 0.09% | 103 |
|
|
2024
Q1 | $24.4K | Hold |
714
| – | – | 0.09% | 99 |
|
|
2023
Q4 | $20.7K | Hold |
714
| – | – | 0.13% | 97 |
|
|
2023
Q3 | $19.7K | Hold |
714
| – | – | 0.14% | 95 |
|
|
2023
Q2 | $21.5K | Hold |
714
| – | – | 0.15% | 94 |
|
|
2023
Q1 | $25.9K | Buy |
+714
| New | +$25.9K | 0.18% | 87 |
|
|
2017
Q4 | $333K | Sell |
8,355
-709
| -8% | -$28.3K | ﹤0.01% | 434 |
|
|
2017
Q3 | $363K | Sell |
9,064
-564
| -6% | -$22.6K | ﹤0.01% | 325 |
|
|
2017
Q2 | $415K | Sell |
9,628
-287
| -3% | -$12.4K | ﹤0.01% | 330 |
|
|
2017
Q1 | $310K | Buy |
+9,915
| New | +$310K | ﹤0.01% | 378 |
|
|
2014
Q3 | – | Sell |
-2,498
| Closed | -$27K | – | 1847 |
|
|
2014
Q2 | $27K | Buy |
+2,498
| New | +$27K | ﹤0.01% | 2268 |
|